Loading...
•
Mar 26, 2022
Charles River Labs Q1 2022 Earnings Report
Charles River Labs reported first-quarter results with revenue of $913.9 million and GAAP earnings per share of $1.81.
Key Takeaways
Charles River Laboratories International, Inc. reported first-quarter revenue of $913.9 million, a 10.8% increase from the first quarter of 2021. GAAP earnings per share were $1.81, and non-GAAP earnings per share were $2.75. The company updated its 2022 financial guidance, increasing reported revenue growth guidance by 50 basis points.
First-quarter revenue was $913.9 million, up 10.8% year-over-year.
First-quarter GAAP earnings per share were $1.81, a 50.8% increase year-over-year.
First-quarter non-GAAP earnings per share were $2.75, an 8.7% increase year-over-year.
The company updated its 2022 financial guidance, increasing reported revenue growth guidance.
Revenue by Segment
Forward Guidance
The Company is updating its 2022 financial guidance, which was previously provided on February 16, 2022. Reported revenue growth guidance is being increased by 50 basis points to 13.5% to 15.5% to reflect the Explora BioLabs acquisition, which was completed on April 5, 2022, partially offset by unfavorable movements in foreign currency translation. Organic revenue growth guidance remains unchanged for 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...